Health Care/Hospital

Moving ahead: Copan announces a major rebranding and launches a new website

BRESCIA, Italy, June 25, 2021 /PRNewswire/ -- Time of change for Copan. The Italian preanalytics company announced the completion of an extensive rebranding initiative which includes a new logo and a new website with updated functionalities. The rebranding aims to represent at best the company va...

2021-06-25 08:25 2691

Innovent Releases Results of a Phase 1 Clinical Study of IBI362, a Glucagon-like Peptide-1 and Glucagon Receptor Dual Agonist in Overweight or Obese Chinese Participants at the American Diabetes Association's 81st Scientific Sessions

SAN FRANCISCO and SUZHOU, China, June 25, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...

2021-06-25 08:00 5510

Bridge Biotherapeutics Integrates CDD Vault Collaborative Database Solution into Its R&D Platform to Harmonize Research and Drug Discovery Project Management

- Bridge has been enhancing its research and drug discovery engines by efficiently managing scientific assets on a collaborative database solution - CDD provides a secure research database platform enabling seamless collaboration between drug discovery and development teams that are in different...

2021-06-25 05:57 1998

Armani beauty Hosts A Skin & Metabolite Conference

PARIS, June 25, 2021 /PRNewswire/ -- On June 24th Armani beauty hosted its first scientific conference focused on SKIN & METABOLITE. The event was held with the participation of renowned scientists who shared their research, highlighting the application potential of Metabolomic Indicators as a pr...

2021-06-25 00:55 2729

Triastek Closes US$ 50 Million Series B Financing, Co-led by Matrix Partners China and CPE

NANJING, China, June 24, 2021 /PRNewswire/ -- Triastek, Inc. (Triastek), a global leader in 3D printed pharmaceuticals, has completed its Series B financing, raisingUS$ 50 million (RMB 330 million). This round of investment was co-led by Matrix Partners China and CPE, with participation from S...

2021-06-25 00:26 2617

GenesisCare Expands their MR-guided Radiotherapy Reach with the Purchase of Multiple MRIdian® Systems

Master agreement includes program plans for up to a further 14 systems with immediate expansion in 2 key markets CLEVELAND, June 24, 2021 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced that GenesisCare has entered into a master purchase agreement for up to 14 MRIdian® MR-Guided The...

2021-06-24 22:33 14166

Licensing Partner of Shenzhen Chipscreen Biosciences - HUYABIO International, Receives Regulatory Approval for Chidamide Monotherapy of Adult T-cell Leukemia/lymphoma in Japan

SHENZHEN, China, June 24, 2021 /PRNewswire/ -- Shenzhen Chipscreen Biosciences' licensing partner, HUYABIO International (HUYABIO™), today announced the regulatory approval for Tucidinostat (also known as Chidamide, Epidaza ®, HBI-8000) monotherapy of relapsed or refractory (R/R) adult T-cell le...

2021-06-24 19:00 2034

Advanced Aesthetic Technologies, Inc. Announces the Treatment of the First Patient in a Pivotal Clinical Trial in China with their Algeness® VL (2.5% Agarose Gel) Filler for the Correction of Moderate to Severe Nasolabial Folds

This new clinical trial is being conducted through their partnership with Lanzhou Biotechnique Development Co., LTD (LanDev) and their parent company China National Biotec Group Co., LTD (CNBG) and will be used to seek marketing approval inChina BROOKLINE, Mass., June 24, 2021 /PRNewswire/ -- Ad...

2021-06-24 18:00 1907

Pine Care Group announces its 2021 Annual Results

HONG KONG, June 24, 2021 /PRNewswire/ -- Highlights * Revenue increased by 13% to HK$245.7 million, mainly driven by the ramp-up in the occupancy rate of Pine Care Place, full year impact of operation of Pine Care Point; and increase in average monthly residential fee of its eight EA 1 care a...

2021-06-24 17:46 24543

Long-Term COVID-19 Fears Drive Major Shift in Household Savings in Asia

HONG KONG, June 24, 2021 /PRNewswire/ -- AIA Group Limited ("AIA"; or the "Company"; stock code: 1299)  announced today the results of a survey on the impact of COVID 19 on household savings, revealing that as many as 71 per cent of consumers plan to save more, driven by fear and insecurity ari...

2021-06-24 15:14 23594

Boan Biotech Publishes Research Results for CEA/CD3 Bispecific Antibody in Antibody Therapeutics

BOSTON, June 24, 2021 /PRNewswire/ -- Luye Pharma Group's subsidiary Boan Biotech recently published research results for its innovative in-house bispecific antibody BA1202 (CEA/CD3 bispecific T-cell engager) inAntibody Therapeutics. Screensh...

2021-06-24 14:49 2646

China's first CAR-T Cell Therapy approved-Fosun Kite Axicabtagene Ciloleucel (FKC876)

* The first* CAR-T cell therapy approved by NMPA: opening a new era of cell therapy inChina * Individualized living-cell-based medicine: genetically modify patient's T-cells to expresses a chimeric antigen receptor (CAR) that will activate T-cells upon engaging cells carrying the specific ant...

2021-06-24 14:46 1832

CStone announces positive GAVRETO® (pralsetinib) registrational study data for first-line treatment of advanced RET fusion-positive non-small cell lung cancer and plans to submit a new indication application

* Key efficacy data showed that GAVRETO demonstrated deep and durable clinical activity in Chinese patients with RET fusion-positive non-small cell lung cancer (NSCLC) * CStone plans to submit new indication application to the China National Medical Products Administration for GAVRETO as a fi...

2021-06-24 08:05 5728

BLS International partners with Knowledge Catalyst to issue Digital Health Certificates

SINGAPORE, June 24, 2021 /PRNewswire/ -- BSE and NSE listed (BSE: 540073; NSE: BLS), BLS International, a trusted global tech-enabled services partner for governments and citizens, announced today that it has entered into a partnership agreement with aSingapore-based company, Knowledge Catalyst t...

2021-06-24 08:00 4842

Endurance RP Limited: A New Name, A New Perspective Eye on China's fertility and longevity market

HONG KONG, June 23, 2021 /PRNewswire/ -- Endurance RP Limited ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK) is pleased to announce the official completion of the rebranding of the Group, with the Company name changed to "Endurance RP...

2021-06-23 22:33 15348

IMPRESSION - A randomised trial to evaluate the efficacy of MagicTouch Sirolimus Coated Balloon in Dysfunctional Fistula progresses rapidly

SINGAPORE, June 23, 2021 /PRNewswire/ -- Concept Medical Inc.,  focused on vascular intervention drug delivery devices, has updated the progress ofIMPRESSION

2021-06-23 19:02 2140

Biocytogen Completes a New Round of Financing Totaling Tens of Millions of Dollars

BEIJING, June 23, 2021 /PRNewswire/ -- Biocytogen , an international biotechnology company focused on antibody drug research and development (R&D) using innovative genetically engineered animal models, today announced the successful completion of a new round of financing ...

2021-06-23 17:02 1815

Envirotainer Welcomes Qatar Airways Cargo as the latest airline to approve the new Releye® RLP

STOCKHOLM, June 23, 2021 /PRNewswire/ -- Envirotainer, the global market leader in secure cold chain solutions for air transportation of pharmaceuticals, today announced that Qatar Airways Cargo has approved the Envirotainer Releye® RLP container for their fleet of aircraft. With this approval, t...

2021-06-23 16:55 1349

Clinical Application of Lunit AI For Chest Radiography and Mammography to Be Presented at AOCR 2021

* Two South Korean radiologists share benefits and feedback of using AI products for chest x-rays and mammograms in an actual patient care * Company expects to deliver the diagnostic value of AI and expand its implementation across clinical sites in theAsia-Pacific region SEOUL, June 23, 2021...

2021-06-23 10:28 2723

Sintilimab in Combination with Chemotherapy Meets Overall Survival Primary Endpoint in the Global Phase 3 ORIENT-15 Study for the First-Line Treatment of Esophageal Squamous Cell Carcinoma

SAN FRANCISCO and SUZHOU, China, June 23, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...

2021-06-23 09:16 19823
1 ... 317318319320321322323 ... 554